A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Kumar emphasized the importance of working with a physician to choose a weight-loss medication that matches the patient’s personal goals and health status. "Both Wegovy and Zepbound have ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...